NDC Package 0009-0306-02 Depo-medrol

Methylprednisolone Acetate Injection, Suspension Intralesional; Intramuscular; - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
0009-0306-02
Package Description:
5 mL in 1 VIAL, MULTI-DOSE
Product Code:
Proprietary Name:
Depo-medrol
Non-Proprietary Name:
Methylprednisolone Acetate
Substance Name:
Methylprednisolone Acetate
Usage Information:
Methylprednisolone is used to treat pain and swelling that occurs with arthritis and other joint disorders. This medication may also be used to treat various conditions such as blood disorders, severe allergic reactions, certain cancers, eye conditions, skin/intestinal/kidney/lung diseases, and immune system disorders. It decreases your immune system's response to these conditions and reduces symptoms such as swelling, pain, and allergic-type reactions. Talk to your doctor about the risks and benefits of methylprednisolone, especially if it is to be injected near your spine (epidural). Rare but serious side effects may occur with epidural use. Methylprednisolone is a corticosteroid hormone. Methylprednisolone may also be used with other medications in hormone disorders.
11-Digit NDC Billing Format:
00009030602
Billing Unit:
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
NDC to RxNorm Crosswalk:
5 ML
NDC to RxNorm Crosswalk:
  • RxCUI: 1358510 - methylPREDNISolone acetate 20 MG/ML Injectable Suspension
  • RxCUI: 1358510 - methylprednisolone acetate 20 MG/ML Injectable Suspension
  • RxCUI: 1358512 - DEPO-Medrol 20 MG/ML Injectable Suspension
  • RxCUI: 1358512 - methylprednisolone acetate 20 MG/ML Injectable Suspension [Depo-Medrol]
  • RxCUI: 1358512 - Depo-Medrol 20 MG/ML Injectable Suspension
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Pharmacia & Upjohn Company Llc
    Dosage Form:
    Injection, Suspension - A liquid preparation, suitable for injection, which consists of solid particles dispersed throughout a liquid phase in which the particles are not soluble. It can also consist of an oil phase dispersed throughout an aqueous phase, or vice-versa.
    Administration Route(s):
  • Intralesional - Administration within or introduced directly into a localized lesion.
  • Intramuscular - Administration within a muscle.
  • Intrasynovial - Administration within the synovial cavity of a joint.
  • Soft Tissue - Administration into any soft tissue.
  • Sample Package:
    No
    FDA Application Number:
    NDA011757
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    05-28-1959
    Listing Expiration Date:
    12-31-2025
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    NDC HCPCS Crosswalk

    This crosswalk is intended to help the public understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes.

    NDC 0009-0306-02 HCPCS crosswalk information with package details and bill units information.

    NDC Billing CodeHCPCS CodeHCPCS Code Desc.DosagePackage SizePackage QuantityBillable UnitsBillable Units / Pkg
    00009030602J1040Methylprednisolone 80 mg inj80 MG5155

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    0009-0306-1225 VIAL, MULTI-DOSE in 1 PACKAGE / 5 mL in 1 VIAL, MULTI-DOSE

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 0009-0306-02?

    The NDC Packaged Code 0009-0306-02 is assigned to a package of 5 ml in 1 vial, multi-dose of Depo-medrol, a human prescription drug labeled by Pharmacia & Upjohn Company Llc. The product's dosage form is injection, suspension and is administered via intralesional; intramuscular; intrasynovial; soft tissue form.

    Is NDC 0009-0306 included in the NDC Directory?

    Yes, Depo-medrol with product code 0009-0306 is active and included in the NDC Directory. The product was first marketed by Pharmacia & Upjohn Company Llc on May 28, 1959 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 0009-0306-02?

    The contents of this package are billed per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume. The calculated billable units for this package is 5.

    What is the 11-digit format for NDC 0009-0306-02?

    The 11-digit format is 00009030602. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    4-4-20009-0306-025-4-200009-0306-02